EBR

Ebr Systems Inc.

Health Care Equipment & Services

EBR Systems Inc. is a medical device company specializing in innovative solutions for cardiac rhythm management, focusing on leadless pacing technology. Their WiSE System offers a unique, physiologic approach to treating heart failure, setting them apart in the healthcare equipment sector.

Medical Devices

Cardiac Care

Innovation

Health Technology

Shorted

short percentage0.01%

reported shorts22.9K

shares on issue450.037M

About

website

ebrsystemsinc.com

industry

Health Care Equipment & Services

address

251 Little Falls Drive, WILMINGTON, DE, UNITED STATES OF AMERICA, 19808

Connect

Key Metrics

market cap

$373.72M

eps$-0.17

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

View all stocks in this industry

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Medical Devices

Cardiac Care

Innovation

Health Technology

Leadless Pacing

Company Overview

AI-generated company summary

Company History

Founded in Silicon Valley in 2003, EBR Systems Inc. has been at the forefront of cardiac rhythm management innovation. The company initiated its first human clinical trial for the WiSE technology in 2011 and achieved the world's first totally leadless CRT implant in 2018. In 2019, they received the FDA Breakthrough Device Designation, and by 2023, their pivotal SOLVE-CRT trial showed positive interim results.

Competitive Advantages

EBR Systems Inc. offers a groundbreaking leadless pacing technology that eliminates the complications associated with traditional leads in cardiac devices. Their WiSE System is the first of its kind, providing a versatile and physiologic approach to heart pacing, which has been recognized with FDA Breakthrough Device Designation.

Risk Factors

•Regulatory approval challenges
•Technological advancements by competitors
•Market adoption of new technology

Recent Developments

Last 6 months

In 2023, EBR Systems' WiSE System pivotal SOLVE-CRT trial was stopped early due to positive interim results, indicating strong potential for FDA approval.

Key People

Leadership team at Ebr Systems Inc.

John Smith

Simon Adams

Financial Reports

22 reports available

Annual Report

Annual ReportApr 14, 2025via asx_announcements

Appendix 4E SEC Form 10K

Annual ResultsMar 25, 2025via asx_announcements

Quarterly Cash Flow Report

Quarterly ReportMar 25, 2025via asx_announcements

Notice of Date for Q3 2024 Quarterly Report and Form 10-Q

Quarterly ReportOct 25, 2024via asx_announcements

Appendix 4D and Half Year Report & Accounts

Half Year ResultsAug 27, 2024via asx_announcements

EBR Half Year Results 2024 and Securityholder Update

Half Year ResultsAug 27, 2024via asx_announcements

Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly ReportJul 26, 2024via asx_announcements

Annual Report to Stockholders

Annual ReportApr 30, 2024via asx_announcements

Quarterly Activities/Appendix 4C Cash Flow Report

Quarterly ReportApr 26, 2024via asx_announcements

Appendix 4E and FY2023 Consolidated Financial Statements

Annual ResultsFeb 28, 2024via asx_announcements

Showing 10 of 22 reports